Multiplex immunofluorescence analysis in two of the analysed patients also showed CD68+ macrophage populations (specifically CD68+CD163+ myeloid cells expressing PD-L1) after CAN-3110 treatment, particularly in perinecrotic tumour regions (Extended Data Fig. 7f–i). The gene discussed is CD68; the disease is neoplasm.